Global Atropine Sulfate Market Size, Share and Trends Analysis Report, By Product Type (Injection, Drops, Gel, Tablet), By Application (Gastrointestinal, Ophthalmology, Neurology, Other), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Forecast (2022-2028)
The global atropine sulfate market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Atropine sulfate is used to treat a certain type of nerve agent and pesticide poisonings to reduce saliva, mucus, and other secretions during surgery. Therising market intervention by key market players is attracting the attention of investors across the globe. Atropine sulphate is used in the eye to increase the pupil size during the diagnosis of uveitis and early amblyopia. In addition, it is given intravenously or intramuscularly to treat bradycardia as the injection solution usually begins to work within a minute and lasts half an hour to one hour. Large doses may be needed to treat certain toxins. Atropine also acts as an antidote over toxins caused by organophosphate nerve toxins. The large application areas of this drug is further contributing to its market growth.
Looking towards the growing application areas of atropine sulphate, key market players such as Alchem International Pvt. Ltd., and Centroflora Group among others are adopting several growth strategies such new product launch and filing for FDA approval to remain competitive in the market place. For instance, in December 2021, Apotex Corp. has received approval and granted a Competitive Generic Therapy signation for its generic version of Atropine Sulfate Ophthalmic Solution USP, 1.0% by the US FDA. As the first approved application , Apotex has been granted 180 days of Competitive Generic Therapy exclusivity.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Product Type
- By Application
- By Distribution Channel
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape-Alchem International Pvt. Ltd., Centroflora Group, Minsheng Group Shaoxing Pharmaceutical Co. Ltd., Novartis AG, and Resonance Laboratories Pvt. Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Atropine Sulfate Market Report by Segment
By Product Type
- Injection
- Drops
- Gel
- Tablet
By Application
- Ophthalmology
- Gastrointestinal
- Neurology
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Atropine Sulfate Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
The report will be delivered within 48-72 hours after payment confirmation